Company intelligence / Profile preview

Adagio Medical Holdings

Laguna Hills, California, United States

Ownership: Private
Development stage: Other

Overview

Adagio Medical Holdings is an early commercial stage medical device company developing and commercializing ultra-low temperature cryoablation and pulsed-field ablation catheter systems (iCLAS, vCLAS, CryoPulse) for treatment of cardiac arrhythmias, with products placed on the EU market and early commercialization activities in progress.[1][3][4]

Therapeutic areas: Cardiovascular
Modalities: DeviceNon-pharmacological therapy
Industry: Surgical Medical Devices

Beyond the preview

Go deeper on Adagio Medical Holdings.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Adagio Medical Holdings.

Explore the full profile